Form 4: Scholar Rock CSO Sells Shares for Tax Obligations

Scholar Rock Holding Corp's Chief Scientific Officer, Mo Qatanani, sold 3,178 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Mo Qatanani, Chief Scientific Officer of Scholar Rock Holding Corp (SRRK), reported a sale of common stock.
• The transaction involved the disposition of 3,178 shares at a price of $33.52 per share.
• This sale was a "sell to cover" transaction, mandated by the issuer to fund tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• The RSUs vested on September 15, 2025, and were granted on October 26, 2021, and October 10, 2022.
• Following this transaction, Mo Qatanani beneficially owns 112,317 securities, comprising 3,353 shares of common stock and 108,964 RSUs.

Sentiment

Score: 5

Explanation: The transaction is a non-discretionary "sell to cover" for tax purposes, which is a routine event and does not indicate a positive or negative sentiment towards the company's stock.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• The sale does not represent a discretionary trade by the reporting person, as it was mandated by the Issuer's election under its equity incentive plans to fund tax withholding obligations through a "sell to cover" transaction.

Industry Context

A "sell to cover" transaction is a common and standard practice in the industry for executives to satisfy tax liabilities arising from the vesting of equity awards like restricted stock units. It does not typically reflect specific industry trends or competitive positioning.

Comparison to Industry Standards

• This type of transaction is a routine and expected event for executives receiving equity compensation across publicly traded companies. It aligns with standard practices for managing tax obligations upon RSU vesting, similar to what is observed at comparable biotech or pharmaceutical firms where equity compensation is prevalent.

Stakeholder Impact

• Minimal impact on shareholders as it is a routine tax-related transaction by an officer, not a discretionary sale reflecting a change in sentiment or outlook on the company's prospects.

Key Dates

Recommendation

The reported transaction is a non-discretionary 'sell to cover' to satisfy tax obligations related to RSU vesting. This is a routine event for executives with equity compensation and does not reflect a change in the reporting person's outlook on the company's prospects or a discretionary decision to reduce holdings. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Scholar Rock, SRRK, Mo Qatanani, Form 4, insider transaction, stock sale, RSU, restricted stock units, sell to cover, tax withholding